nodes	percent_of_prediction	percent_of_DWPC	metapath
Podofilox—TUBA4A—Vincristine—colon cancer	0.61	0.706	CbGbCtD
Podofilox—TUBB—Vincristine—colon cancer	0.233	0.269	CbGbCtD
Podofilox—CYP3A4—Irinotecan—colon cancer	0.0114	0.0131	CbGbCtD
Podofilox—CYP3A4—Vincristine—colon cancer	0.00992	0.0115	CbGbCtD
Podofilox—Balanoposthitis—Capecitabine—colon cancer	0.00815	0.111	CcSEcCtD
Podofilox—Wound secretion—Capecitabine—colon cancer	0.00589	0.0804	CcSEcCtD
Podofilox—Scab—Fluorouracil—colon cancer	0.00385	0.0525	CcSEcCtD
Podofilox—Localized exfoliation—Capecitabine—colon cancer	0.00317	0.0433	CcSEcCtD
Podofilox—Application site pain—Fluorouracil—colon cancer	0.00278	0.0379	CcSEcCtD
Podofilox—Scab—Capecitabine—colon cancer	0.00269	0.0367	CcSEcCtD
Podofilox—TUBA4A—epithelium—colon cancer	0.0023	0.0678	CbGeAlD
Podofilox—TUBA4A—smooth muscle tissue—colon cancer	0.00221	0.0653	CbGeAlD
Podofilox—TUBA4A—renal system—colon cancer	0.00213	0.0629	CbGeAlD
Podofilox—TOP2A—Topotecan—Irinotecan—colon cancer	0.00185	0.404	CbGdCrCtD
Podofilox—TUBA4A—lymphoid tissue—colon cancer	0.00177	0.0522	CbGeAlD
Podofilox—TUBA4A—digestive system—colon cancer	0.00175	0.0516	CbGeAlD
Podofilox—Blister—Fluorouracil—colon cancer	0.0017	0.0231	CcSEcCtD
Podofilox—TUBB—smooth muscle tissue—colon cancer	0.00162	0.0479	CbGeAlD
Podofilox—TUBA4A—bone marrow—colon cancer	0.00161	0.0475	CbGeAlD
Podofilox—TUBA4A—vagina—colon cancer	0.00154	0.0455	CbGeAlD
Podofilox—Tingling sensation—Fluorouracil—colon cancer	0.00152	0.0208	CcSEcCtD
Podofilox—Stinging—Fluorouracil—colon cancer	0.00151	0.0206	CcSEcCtD
Podofilox—NR3C1—Regulation of Androgen receptor activity—SPDEF—colon cancer	0.00144	0.0647	CbGpPWpGaD
Podofilox—Tenderness—Fluorouracil—colon cancer	0.0014	0.0191	CcSEcCtD
Podofilox—Etoposide—PTGS2—colon cancer	0.0014	0.541	CrCbGaD
Podofilox—Ulcer—Irinotecan—colon cancer	0.00135	0.0184	CcSEcCtD
Podofilox—TOP2A—Vindesine—Vincristine—colon cancer	0.00132	0.289	CbGdCrCtD
Podofilox—TUBA4A—liver—colon cancer	0.0013	0.0384	CbGeAlD
Podofilox—Ulcer—Fluorouracil—colon cancer	0.00129	0.0176	CcSEcCtD
Podofilox—Inflammation—Fluorouracil—colon cancer	0.00126	0.0172	CcSEcCtD
Podofilox—TOP2A—bone marrow—colon cancer	0.00119	0.0352	CbGeAlD
Podofilox—Etoposide—ABCB1—colon cancer	0.00119	0.46	CrCbGaD
Podofilox—Blister—Capecitabine—colon cancer	0.00119	0.0162	CcSEcCtD
Podofilox—TUBB—bone marrow—colon cancer	0.00118	0.0348	CbGeAlD
Podofilox—TOP2A—vagina—colon cancer	0.00114	0.0337	CbGeAlD
Podofilox—TUBB—vagina—colon cancer	0.00113	0.0334	CbGeAlD
Podofilox—Skin ulcer—Capecitabine—colon cancer	0.0011	0.015	CcSEcCtD
Podofilox—Tingling sensation—Capecitabine—colon cancer	0.00106	0.0145	CcSEcCtD
Podofilox—Swelling—Fluorouracil—colon cancer	0.00101	0.0137	CcSEcCtD
Podofilox—TUBA4A—lymph node—colon cancer	0.000999	0.0295	CbGeAlD
Podofilox—NR3C1—embryo—colon cancer	0.000957	0.0282	CbGeAlD
Podofilox—TUBB—liver—colon cancer	0.000955	0.0282	CbGeAlD
Podofilox—Skin discolouration—Capecitabine—colon cancer	0.000946	0.0129	CcSEcCtD
Podofilox—Dermatitis bullous—Fluorouracil—colon cancer	0.000929	0.0127	CcSEcCtD
Podofilox—Ulcer—Capecitabine—colon cancer	0.000904	0.0123	CcSEcCtD
Podofilox—Inflammation—Capecitabine—colon cancer	0.000881	0.012	CcSEcCtD
Podofilox—TOP2A—Vinorelbine—Vincristine—colon cancer	0.000834	0.182	CbGdCrCtD
Podofilox—Skin ulcer—Methotrexate—colon cancer	0.000817	0.0111	CcSEcCtD
Podofilox—Skin exfoliation—Capecitabine—colon cancer	0.000816	0.0111	CcSEcCtD
Podofilox—Dry skin—Fluorouracil—colon cancer	0.000814	0.0111	CcSEcCtD
Podofilox—NR3C1—epithelium—colon cancer	0.000781	0.023	CbGeAlD
Podofilox—CYP2C19—digestive system—colon cancer	0.00076	0.0224	CbGeAlD
Podofilox—NR3C1—smooth muscle tissue—colon cancer	0.000752	0.0222	CbGeAlD
Podofilox—TOP2A—lymph node—colon cancer	0.000739	0.0218	CbGeAlD
Podofilox—TUBB—lymph node—colon cancer	0.000732	0.0216	CbGeAlD
Podofilox—NR3C1—renal system—colon cancer	0.000724	0.0213	CbGeAlD
Podofilox—Skin discolouration—Methotrexate—colon cancer	0.000705	0.00961	CcSEcCtD
Podofilox—Swelling—Capecitabine—colon cancer	0.000703	0.00959	CcSEcCtD
Podofilox—Ulcer—Methotrexate—colon cancer	0.000673	0.00918	CcSEcCtD
Podofilox—CYP2C19—vagina—colon cancer	0.000671	0.0198	CbGeAlD
Podofilox—Inflammation—Methotrexate—colon cancer	0.000656	0.00895	CcSEcCtD
Podofilox—Dermatitis bullous—Capecitabine—colon cancer	0.000649	0.00885	CcSEcCtD
Podofilox—Haemoglobin—Irinotecan—colon cancer	0.000645	0.00879	CcSEcCtD
Podofilox—Haemorrhage—Irinotecan—colon cancer	0.000641	0.00875	CcSEcCtD
Podofilox—Haemoglobin—Fluorouracil—colon cancer	0.000617	0.00842	CcSEcCtD
Podofilox—Haemorrhage—Fluorouracil—colon cancer	0.000614	0.00838	CcSEcCtD
Podofilox—Skin exfoliation—Methotrexate—colon cancer	0.000608	0.00829	CcSEcCtD
Podofilox—NR3C1—lymphoid tissue—colon cancer	0.000601	0.0177	CbGeAlD
Podofilox—NR3C1—digestive system—colon cancer	0.000594	0.0175	CbGeAlD
Podofilox—Immune system disorder—Irinotecan—colon cancer	0.000579	0.0079	CcSEcCtD
Podofilox—TOP2A—Vinblastine—Vincristine—colon cancer	0.000574	0.125	CbGdCrCtD
Podofilox—Dry skin—Capecitabine—colon cancer	0.000569	0.00776	CcSEcCtD
Podofilox—CYP2C19—liver—colon cancer	0.000566	0.0167	CbGeAlD
Podofilox—CYP3A4—renal system—colon cancer	0.000548	0.0161	CbGeAlD
Podofilox—NR3C1—bone marrow—colon cancer	0.000547	0.0161	CbGeAlD
Podofilox—Erythema—Fluorouracil—colon cancer	0.000535	0.00729	CcSEcCtD
Podofilox—NR3C1—vagina—colon cancer	0.000524	0.0155	CbGeAlD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—MSH6—colon cancer	0.000521	0.0234	CbGpPWpGaD
Podofilox—NR3C1—Nuclear Receptors—HNF4A—colon cancer	0.000481	0.0217	CbGpPWpGaD
Podofilox—Oedema—Vincristine—colon cancer	0.000468	0.00638	CcSEcCtD
Podofilox—Haematuria—Capecitabine—colon cancer	0.000456	0.00622	CcSEcCtD
Podofilox—Oedema—Irinotecan—colon cancer	0.000456	0.00621	CcSEcCtD
Podofilox—CYP3A4—digestive system—colon cancer	0.000449	0.0132	CbGeAlD
Podofilox—NR3C1—liver—colon cancer	0.000442	0.013	CbGeAlD
Podofilox—TOP2A—Gastric Cancer Network 1—APC—colon cancer	0.000439	0.0197	CbGpPWpGaD
Podofilox—Oedema—Fluorouracil—colon cancer	0.000436	0.00595	CcSEcCtD
Podofilox—Haemoglobin—Capecitabine—colon cancer	0.000431	0.00588	CcSEcCtD
Podofilox—Haemorrhage—Capecitabine—colon cancer	0.000429	0.00585	CcSEcCtD
Podofilox—NR3C1—FOXA2 and FOXA3 transcription factor networks—HNF4A—colon cancer	0.000428	0.0193	CbGpPWpGaD
Podofilox—Insomnia—Vincristine—colon cancer	0.000423	0.00577	CcSEcCtD
Podofilox—Paraesthesia—Vincristine—colon cancer	0.00042	0.00573	CcSEcCtD
Podofilox—Insomnia—Irinotecan—colon cancer	0.000412	0.00562	CcSEcCtD
Podofilox—Paraesthesia—Irinotecan—colon cancer	0.000409	0.00558	CcSEcCtD
Podofilox—TUBA4A—Pathogenic Escherichia coli infection—CDH1—colon cancer	0.000407	0.0183	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—CHST4—colon cancer	0.000402	0.0181	CbGpPWpGaD
Podofilox—Pain—Vincristine—colon cancer	0.0004	0.00546	CcSEcCtD
Podofilox—Insomnia—Fluorouracil—colon cancer	0.000395	0.00538	CcSEcCtD
Podofilox—Paraesthesia—Fluorouracil—colon cancer	0.000392	0.00534	CcSEcCtD
Podofilox—Pain—Irinotecan—colon cancer	0.00039	0.00531	CcSEcCtD
Podofilox—Immune system disorder—Capecitabine—colon cancer	0.000388	0.00529	CcSEcCtD
Podofilox—NR3C1—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.00038	0.0171	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.000376	0.0169	CbGpPWpGaD
Podofilox—Erythema—Capecitabine—colon cancer	0.000374	0.0051	CcSEcCtD
Podofilox—Pain—Fluorouracil—colon cancer	0.000373	0.00509	CcSEcCtD
Podofilox—TOP2A—Circadian rythm related genes—TOP1—colon cancer	0.000361	0.0162	CbGpPWpGaD
Podofilox—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—colon cancer	0.000354	0.0159	CbGpPWpGaD
Podofilox—TUBB—Pathogenic Escherichia coli infection—CDH1—colon cancer	0.000346	0.0156	CbGpPWpGaD
Podofilox—CYP3A4—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000346	0.0156	CbGpPWpGaD
Podofilox—Haematuria—Methotrexate—colon cancer	0.000339	0.00463	CcSEcCtD
Podofilox—NR3C1—lymph node—colon cancer	0.000339	0.01	CbGeAlD
Podofilox—TUBA4A—Cell Cycle—MLH3—colon cancer	0.000336	0.0151	CbGpPWpGaD
Podofilox—CYP3A4—liver—colon cancer	0.000335	0.00987	CbGeAlD
Podofilox—NR3C1—Transcription factor regulation in adipogenesis—PPARG—colon cancer	0.000324	0.0146	CbGpPWpGaD
Podofilox—Haemoglobin—Methotrexate—colon cancer	0.000321	0.00438	CcSEcCtD
Podofilox—Haemorrhage—Methotrexate—colon cancer	0.00032	0.00436	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000316	0.00431	CcSEcCtD
Podofilox—Dizziness—Vincristine—colon cancer	0.000309	0.00422	CcSEcCtD
Podofilox—Pruritus—Fluorouracil—colon cancer	0.000309	0.00421	CcSEcCtD
Podofilox—Oedema—Capecitabine—colon cancer	0.000305	0.00416	CcSEcCtD
Podofilox—Dizziness—Irinotecan—colon cancer	0.000301	0.00411	CcSEcCtD
Podofilox—TUBA4A—Pathogenic Escherichia coli infection—CTNNB1—colon cancer	0.0003	0.0135	CbGpPWpGaD
Podofilox—Vomiting—Vincristine—colon cancer	0.000298	0.00406	CcSEcCtD
Podofilox—Skin disorder—Capecitabine—colon cancer	0.000296	0.00404	CcSEcCtD
Podofilox—Rash—Vincristine—colon cancer	0.000295	0.00402	CcSEcCtD
Podofilox—Dermatitis—Vincristine—colon cancer	0.000295	0.00402	CcSEcCtD
Podofilox—Headache—Vincristine—colon cancer	0.000293	0.004	CcSEcCtD
Podofilox—Vomiting—Irinotecan—colon cancer	0.00029	0.00395	CcSEcCtD
Podofilox—Immune system disorder—Methotrexate—colon cancer	0.000289	0.00394	CcSEcCtD
Podofilox—Dizziness—Fluorouracil—colon cancer	0.000289	0.00394	CcSEcCtD
Podofilox—Rash—Irinotecan—colon cancer	0.000287	0.00392	CcSEcCtD
Podofilox—Dermatitis—Irinotecan—colon cancer	0.000287	0.00392	CcSEcCtD
Podofilox—Headache—Irinotecan—colon cancer	0.000285	0.00389	CcSEcCtD
Podofilox—TUBB—Cell Cycle—MLH3—colon cancer	0.000285	0.0128	CbGpPWpGaD
Podofilox—TOP2A—Gastric Cancer Network 2—CTNNB1—colon cancer	0.000283	0.0127	CbGpPWpGaD
Podofilox—Erythema—Methotrexate—colon cancer	0.000278	0.00379	CcSEcCtD
Podofilox—Vomiting—Fluorouracil—colon cancer	0.000278	0.00378	CcSEcCtD
Podofilox—Insomnia—Capecitabine—colon cancer	0.000276	0.00376	CcSEcCtD
Podofilox—Rash—Fluorouracil—colon cancer	0.000275	0.00375	CcSEcCtD
Podofilox—Dermatitis—Fluorouracil—colon cancer	0.000275	0.00375	CcSEcCtD
Podofilox—Paraesthesia—Capecitabine—colon cancer	0.000274	0.00374	CcSEcCtD
Podofilox—Headache—Fluorouracil—colon cancer	0.000273	0.00373	CcSEcCtD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—HNF4A—colon cancer	0.000263	0.0118	CbGpPWpGaD
Podofilox—Pain—Capecitabine—colon cancer	0.000261	0.00356	CcSEcCtD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.000256	0.0115	CbGpPWpGaD
Podofilox—TUBB—Pathogenic Escherichia coli infection—CTNNB1—colon cancer	0.000255	0.0115	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—TYMS—colon cancer	0.000248	0.0112	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	0.000242	0.0109	CbGpPWpGaD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000235	0.00321	CcSEcCtD
Podofilox—TOP2A—Gastric Cancer Network 2—MYC—colon cancer	0.000229	0.0103	CbGpPWpGaD
Podofilox—TOP2A—Gastric Cancer Network 2—EGFR—colon cancer	0.000224	0.0101	CbGpPWpGaD
Podofilox—Skin disorder—Methotrexate—colon cancer	0.000221	0.00301	CcSEcCtD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.000216	0.00971	CbGpPWpGaD
Podofilox—Pruritus—Capecitabine—colon cancer	0.000216	0.00294	CcSEcCtD
Podofilox—NR3C1—Nuclear Receptors—PPARG—colon cancer	0.000209	0.00941	CbGpPWpGaD
Podofilox—Insomnia—Methotrexate—colon cancer	0.000205	0.0028	CcSEcCtD
Podofilox—Paraesthesia—Methotrexate—colon cancer	0.000204	0.00278	CcSEcCtD
Podofilox—TUBA4A—Metabolism of proteins—CDX2—colon cancer	0.000203	0.00914	CbGpPWpGaD
Podofilox—Dizziness—Capecitabine—colon cancer	0.000202	0.00275	CcSEcCtD
Podofilox—TOP2A—Cell Cycle—MLH3—colon cancer	0.0002	0.00898	CbGpPWpGaD
Podofilox—TUBA4A—Platelet degranulation—VEGFA—colon cancer	0.000196	0.00881	CbGpPWpGaD
Podofilox—Pain—Methotrexate—colon cancer	0.000194	0.00265	CcSEcCtD
Podofilox—Vomiting—Capecitabine—colon cancer	0.000194	0.00264	CcSEcCtD
Podofilox—Rash—Capecitabine—colon cancer	0.000192	0.00262	CcSEcCtD
Podofilox—Dermatitis—Capecitabine—colon cancer	0.000192	0.00262	CcSEcCtD
Podofilox—Headache—Capecitabine—colon cancer	0.000191	0.00261	CcSEcCtD
Podofilox—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.00019	0.00854	CbGpPWpGaD
Podofilox—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000189	0.00852	CbGpPWpGaD
Podofilox—TOP2A—Gastric Cancer Network 2—TP53—colon cancer	0.000188	0.00846	CbGpPWpGaD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	0.000187	0.0084	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—CHST5—colon cancer	0.000184	0.0083	CbGpPWpGaD
Podofilox—TUBA4A—Platelet degranulation—TGFB1—colon cancer	0.00018	0.00809	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—TYMS—colon cancer	0.000175	0.00786	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—MUC2—colon cancer	0.000173	0.00777	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.000173	0.00776	CbGpPWpGaD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	0.000171	0.00771	CbGpPWpGaD
Podofilox—NR3C1—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.000165	0.00743	CbGpPWpGaD
Podofilox—Pruritus—Methotrexate—colon cancer	0.000161	0.00219	CcSEcCtD
Podofilox—CYP3A4—Irinotecan Pathway—APC—colon cancer	0.000159	0.00717	CbGpPWpGaD
Podofilox—TUBA4A—G2/M Transition—EP300—colon cancer	0.000157	0.00706	CbGpPWpGaD
Podofilox—TUBA4A—Mitotic G2-G2/M phases—EP300—colon cancer	0.000155	0.00696	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—BAX—colon cancer	0.000154	0.00691	CbGpPWpGaD
Podofilox—Dizziness—Methotrexate—colon cancer	0.00015	0.00205	CcSEcCtD
Podofilox—TUBA4A—Cell Cycle—MLH1—colon cancer	0.000148	0.00665	CbGpPWpGaD
Podofilox—Vomiting—Methotrexate—colon cancer	0.000144	0.00197	CcSEcCtD
Podofilox—Rash—Methotrexate—colon cancer	0.000143	0.00195	CcSEcCtD
Podofilox—Dermatitis—Methotrexate—colon cancer	0.000143	0.00195	CcSEcCtD
Podofilox—Headache—Methotrexate—colon cancer	0.000142	0.00194	CcSEcCtD
Podofilox—TUBA4A—Cell Cycle, Mitotic—BUB1B—colon cancer	0.00014	0.00632	CbGpPWpGaD
Podofilox—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—colon cancer	0.00014	0.00629	CbGpPWpGaD
Podofilox—NR3C1—Endoderm Differentiation—APC—colon cancer	0.000136	0.00612	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.000135	0.00606	CbGpPWpGaD
Podofilox—TUBB—G2/M Transition—EP300—colon cancer	0.000133	0.006	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.000132	0.00595	CbGpPWpGaD
Podofilox—TUBB—Mitotic G2-G2/M phases—EP300—colon cancer	0.000132	0.00592	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.000127	0.00573	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—TYMS—colon cancer	0.000127	0.00571	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—BUB1B—colon cancer	0.000126	0.00565	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MLH1—colon cancer	0.000126	0.00565	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—colon cancer	0.000125	0.00562	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—colon cancer	0.000121	0.00544	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—BUB1B—colon cancer	0.000119	0.00537	CbGpPWpGaD
Podofilox—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000114	0.00513	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	0.000111	0.00499	CbGpPWpGaD
Podofilox—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000109	0.00489	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—TYMS—colon cancer	0.000108	0.00485	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—BUB1B—colon cancer	0.000107	0.0048	CbGpPWpGaD
Podofilox—NR3C1—Regulation of Androgen receptor activity—EP300—colon cancer	0.000105	0.00472	CbGpPWpGaD
Podofilox—NR3C1—Regulation of Androgen receptor activity—SRC—colon cancer	0.000102	0.00459	CbGpPWpGaD
Podofilox—NR3C1—Circadian Clock—EP300—colon cancer	0.000102	0.00458	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—MYC—colon cancer	0.0001	0.00451	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—APC—colon cancer	9.71e-05	0.00437	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—TYMS—colon cancer	9.63e-05	0.00433	CbGpPWpGaD
Podofilox—NR3C1—Endoderm Differentiation—CTNNB1—colon cancer	9.24e-05	0.00416	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—TYMS—colon cancer	9.16e-05	0.00412	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—CCND1—colon cancer	9.11e-05	0.0041	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—CTNNB1—colon cancer	9.03e-05	0.00406	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—PPARG—colon cancer	9e-05	0.00405	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—SRC—colon cancer	8.92e-05	0.00401	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—CCND1—colon cancer	8.79e-05	0.00396	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MLH1—colon cancer	8.78e-05	0.00395	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—VEGFA—colon cancer	8.69e-05	0.00391	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—CDKN1A—colon cancer	8.51e-05	0.00383	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—EP300—colon cancer	8.39e-05	0.00377	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—BUB1B—colon cancer	8.35e-05	0.00376	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—TP53—colon cancer	8.23e-05	0.0037	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TYMS—colon cancer	8.19e-05	0.00368	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—TGFB1—colon cancer	7.98e-05	0.00359	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—colon cancer	7.84e-05	0.00353	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—PPARG—colon cancer	7.81e-05	0.00352	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—colon cancer	7.77e-05	0.0035	CbGpPWpGaD
Podofilox—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	7.56e-05	0.0034	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—BUB1B—colon cancer	7.47e-05	0.00336	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—colon cancer	7.46e-05	0.00336	CbGpPWpGaD
Podofilox—NR3C1—Endoderm Differentiation—TGFB1—colon cancer	7.46e-05	0.00336	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—EP300—colon cancer	7.39e-05	0.00333	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	7.37e-05	0.00332	CbGpPWpGaD
Podofilox—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	7.35e-05	0.00331	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—MYC—colon cancer	7.31e-05	0.00329	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—TGFB1—colon cancer	7.29e-05	0.00328	CbGpPWpGaD
Podofilox—CYP2C19—Arachidonic acid metabolism—PTGS2—colon cancer	7.27e-05	0.00327	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—MYC—colon cancer	7.05e-05	0.00317	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	6.84e-05	0.00308	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	6.79e-05	0.00305	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	6.66e-05	0.003	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	6.6e-05	0.00297	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—HNF4A—colon cancer	6.57e-05	0.00296	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—colon cancer	6.5e-05	0.00293	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	6.44e-05	0.0029	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—TYMS—colon cancer	6.4e-05	0.00288	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	6.13e-05	0.00276	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—TP53—colon cancer	6e-05	0.0027	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	5.96e-05	0.00268	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—EP300—colon cancer	5.89e-05	0.00265	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	5.81e-05	0.00261	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TYMS—colon cancer	5.73e-05	0.00258	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—AKT1—colon cancer	5.54e-05	0.00249	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—CTNNB1—colon cancer	5.5e-05	0.00247	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CCND1—colon cancer	5.42e-05	0.00244	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—CDKN1A—colon cancer	5.37e-05	0.00242	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	5.34e-05	0.0024	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	5.33e-05	0.0024	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—TP53—colon cancer	5.29e-05	0.00238	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CA7—colon cancer	5.28e-05	0.00238	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CDKN1A—colon cancer	5.25e-05	0.00236	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	5.23e-05	0.00235	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—EP300—colon cancer	4.99e-05	0.00225	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	4.94e-05	0.00222	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CASP3—colon cancer	4.93e-05	0.00222	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CCND1—colon cancer	4.85e-05	0.00218	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CTNNB1—colon cancer	4.75e-05	0.00214	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—EP300—colon cancer	4.73e-05	0.00213	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CDKN1A—colon cancer	4.69e-05	0.00211	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CCND1—colon cancer	4.61e-05	0.00207	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—SRC—colon cancer	4.6e-05	0.00207	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	4.54e-05	0.00204	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	4.51e-05	0.00203	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—VEGFA—colon cancer	4.48e-05	0.00202	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—AKT1—colon cancer	4.47e-05	0.00201	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—EP300—colon cancer	4.46e-05	0.00201	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CDKN1A—colon cancer	4.46e-05	0.00201	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—TGFB1—colon cancer	4.44e-05	0.002	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—NRAS—colon cancer	4.42e-05	0.00199	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—EP300—colon cancer	4.42e-05	0.00199	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	4.39e-05	0.00197	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—MYC—colon cancer	4.35e-05	0.00196	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—EP300—colon cancer	4.24e-05	0.00191	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—TP53—colon cancer	4.21e-05	0.0019	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—VEGFA—colon cancer	4.18e-05	0.00188	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CCND1—colon cancer	4.12e-05	0.00185	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—TGFB1—colon cancer	4.11e-05	0.00185	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—CTNNB1—colon cancer	4e-05	0.0018	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CDKN1A—colon cancer	3.99e-05	0.00179	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—MYC—colon cancer	3.89e-05	0.00175	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—KRAS—colon cancer	3.81e-05	0.00171	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—EP300—colon cancer	3.79e-05	0.00171	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	3.71e-05	0.00167	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—MYC—colon cancer	3.7e-05	0.00166	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PIK3CA—colon cancer	3.5e-05	0.00157	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—TP53—colon cancer	3.38e-05	0.00152	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MYC—colon cancer	3.31e-05	0.00149	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—HRAS—colon cancer	3.24e-05	0.00146	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CCND1—colon cancer	3.22e-05	0.00145	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CHST5—colon cancer	3.2e-05	0.00144	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ODC1—colon cancer	3.2e-05	0.00144	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—TP53—colon cancer	3.19e-05	0.00144	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CA7—colon cancer	3.17e-05	0.00143	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—HNF4A—colon cancer	3.16e-05	0.00142	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDKN1A—colon cancer	3.12e-05	0.0014	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—EP300—colon cancer	2.97e-05	0.00134	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CCND1—colon cancer	2.88e-05	0.0013	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—AKT1—colon cancer	2.86e-05	0.00129	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—PPARG—colon cancer	2.85e-05	0.00128	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN1A—colon cancer	2.79e-05	0.00126	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TP53—colon cancer	2.72e-05	0.00122	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—EP300—colon cancer	2.65e-05	0.00119	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MYC—colon cancer	2.59e-05	0.00116	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MYC—colon cancer	2.31e-05	0.00104	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CHST5—colon cancer	1.92e-05	0.000865	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ODC1—colon cancer	1.92e-05	0.000865	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TP53—colon cancer	1.9e-05	0.000855	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—MYC—colon cancer	1.63e-05	0.000732	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PPARG—colon cancer	1.37e-05	0.000618	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.32e-05	0.000594	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.04e-05	0.000467	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	8.64e-06	0.000389	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ABCB1—colon cancer	8.45e-06	0.00038	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—TYMS—colon cancer	8.3e-06	0.000373	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—MYC—colon cancer	7.83e-06	0.000352	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.39e-06	0.000287	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PPARG—colon cancer	5.88e-06	0.000265	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—AKT1—colon cancer	5.43e-06	0.000244	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ABCB1—colon cancer	5.08e-06	0.000229	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—TYMS—colon cancer	4.99e-06	0.000225	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PTGS2—colon cancer	4.63e-06	0.000208	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—EP300—colon cancer	3.85e-06	0.000173	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PPARG—colon cancer	3.54e-06	0.000159	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PIK3CA—colon cancer	2.85e-06	0.000128	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PTGS2—colon cancer	2.78e-06	0.000125	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—AKT1—colon cancer	2.32e-06	0.000105	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—EP300—colon cancer	2.31e-06	0.000104	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PIK3CA—colon cancer	1.71e-06	7.7e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—AKT1—colon cancer	1.4e-06	6.29e-05	CbGpPWpGaD
